About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Rhesus Macaques With Sudan Ebolavirus Treated Successfully

by Bidita Debnath on August 22, 2016 at 10:34 PM
Font : A-A+

 Rhesus Macaques With Sudan Ebolavirus Treated Successfully

Scientists have successfully treated monkeys several days after the animals were infected with Sudan ebolavirus (SUDV). The study is important, according to the researchers, because no proven treatments against SUDV exist and little is known about the window of opportunity for treating the infection.

The research was funded by the National Institutes of Health (NIH). Scientists identified SUDV and Zaire ebolavirus (EBOV) in 1976, but EBOV has been the more common cause of outbreaks and has been the focus of nearly all treatment and vaccine research. When an EBOV variant swept through West Africa in 2014-15, physicians treated patients with several experimental therapies but it is unknown whether any of those products would be effective against SUDV.

Advertisement


With that need in mind, scientists at the University of Texas Medical Branch (UTMB) tested a new antiviral drug delivered intravenously to rhesus macaques using a lipid nanoparticle platform (LNP) developed by Arbutus Biopharma, based in British Columbia. The RNA-based therapeutic, called a "small-interfering RNA (siRNA)," can target specific genes to prevent viruses from replicating and may offer advantages compared to other medical countermeasures. The LNP delivery system encapsulates the drug, can increase its potency, and allows the bloodstream to deliver the drug to targeted tissues.

As part of the study, funded by NIH's National Institute of Allergy and Infectious Diseases, the UTMB group compared 48 different RNA-based drug formulations. They determined that the most effective formulation prevented replication of SUDV viral protein 35. They subsequently tested this formulation in six macaques given a lethal SUDV dose. Though all animals showed signs of disease, all six macaques recovered after receiving the siRNA-LNP treatment within four days of infection. Two of four animals survived when treated five days after infection.

The researchers are continuing their investigation of siRNA-LNP therapeutics to determine whether the approach could be effective against additional types of Ebola viruses and other hemorrhagic fever viruses.

Source: Eurekalert
Advertisement
Advertisement
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Rhesus Macaques With Sudan Ebolavirus Treated Successfully Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests